- Home
- UAMY vs TERN Comparison
UAMY vs TERN Comparison
Compare UAMY & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UAMY
- TERN
- Stock Information
- Founded
- UAMY 1968
- TERN 2017
- Country
- UAMY United States
- TERN United States
- Employees
- UAMY N/A
- TERN N/A
- Industry
- UAMY Metal Fabrications
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- UAMY Industrials
- TERN Health Care
- Exchange
- UAMY Nasdaq
- TERN Nasdaq
- Market Cap
- UAMY 251.9M
- TERN 298.1M
- IPO Year
- UAMY N/A
- TERN 2021
- Fundamental
- Price
- UAMY $3.20
- TERN $2.40
- Analyst Decision
- UAMY Strong Buy
- TERN Buy
- Analyst Count
- UAMY 3
- TERN 5
- Target Price
- UAMY $2.20
- TERN $18.38
- AVG Volume (30 Days)
- UAMY 4.8M
- TERN 1.3M
- Earning Date
- UAMY 05-13-2025
- TERN 05-12-2025
- Dividend Yield
- UAMY N/A
- TERN N/A
- EPS Growth
- UAMY N/A
- TERN N/A
- EPS
- UAMY N/A
- TERN N/A
- Revenue
- UAMY $14,937,962.00
- TERN N/A
- Revenue This Year
- UAMY $178.78
- TERN N/A
- Revenue Next Year
- UAMY $433.71
- TERN N/A
- P/E Ratio
- UAMY N/A
- TERN N/A
- Revenue Growth
- UAMY 71.84
- TERN N/A
- 52 Week Low
- UAMY $0.21
- TERN $1.87
- 52 Week High
- UAMY $3.60
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- UAMY 69.96
- TERN 40.98
- Support Level
- UAMY $1.69
- TERN $2.22
- Resistance Level
- UAMY $3.60
- TERN $2.43
- Average True Range (ATR)
- UAMY 0.31
- TERN 0.24
- MACD
- UAMY 0.11
- TERN 0.04
- Stochastic Oscillator
- UAMY 79.06
- TERN 52.71
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.